HIV incidence rates in South Africa

HIV/AIDS in South Africa Second Edition

Volumn , Issue , 2010, Pages 74-84

  Gouws, Eleanor ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79956198863     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9781139062404.006     Document Type: Chapter

References (21)

1. Abdool Karim Q, Abdool Karim SS, Singh B, Short R, Ngxongo S. ‘Seroprevalence of HIV infection in rural South Africa.’ AIDS1992; 6: 1535–1539.
2. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. ‘Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.’ PLoS Medicine2005; 2(11): e298.
3. Brookmeyer R, Quinn TC. ‘Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests.’ American Journal of Epidemiology1995; 141: 166–172.
4. Department of Health, South Africa. 1999. National HIV sero-prevalence survey of women attending antenatal clinics in South Africa. Summary report 1998.Pretoria: Health Systems Research and Epidemiology, Department of Health.
5. Department of Health, RSA. 2001. National HIV and syphilis sero-prevalence survey of women attending public antenatal clinics in South Africa. Summary report 2001. Pretoria: Health Systems Research and Epidemiology, Department ofHealth.
6. Department of Health, RSA. 2007. National HIV and syphilis prevalence survey: South Africa 2006. Pretoria: Cluster Health Information, Epidemiology and Research, Department of Health.
7. Dorrington R, Johnson LF, Bradshaw D, Daniel T. The demographic impact of HIV/AIDS in South Africa. National and Provincial indicators for 2006. Centre forActuarial Research, Medical Research Council and the Actuarial Society of South Africa. 2006. (The model and more detailed statistics can be accessed at www. assa.org/aidsmodel.asp)
8. Doyle PR, Millar DB. ‘A general description of an actuarial model application to the HIV epidemic in South Africa.’ Transactions of the Actuarial Society of South Africa 1990; 8: 561–593.
9. Ghys PD, Brown T, Grassly NC, Garnett G, Stanecki K, Stover J, Walker N. ‘The UNAIDS Estimation and Projection Package: A software package to estimate and project national HIV epidemics.’ Sexually Transmitted Infections2004; 80 (Suppl 1): 15–19.
10. Gouws E, Williams BG, Sheppard HW, Enge B, Abdool Karim SS. ‘High incidence of HIV-1 in South Africa using a standardized algorithm for recent HIV seroconversion.’ Journal of Acquired Immune Deficiency Syndrome2002; 29: 531–535.
11. Gregson S, Donnelly CA, Parker CG, Anderson RM. ‘Demographic approaches to the estimation of incidence of HIV-1 infection among adults from age-specific prevalence data in stable endemic conditions.’ AIDS1996; 10: 1689–1697.
12. Hallett T, Zaba B, Todd J, Lopman B, Mwita W, Biraro S, Gregson S, Boerma TJ, on behalf of the ALPHA Network. ‘Estimating incidence from prevalence in generalised HIV epidemics: Methods and validation.’ PLoS Medicine2008; 5(4):e80.
13. Janssens RS, Satten GA, Stramer SL, Rawal BD, O’Brien TR, Weiblen BJ, et al. ‘New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes.’ Journal of the American Medical Association 1998; 280: 42–48.
14. Kustner HGV, Swanevelder JP, Van Middelkoop A. ‘National HIV surveillance – South Africa, 1990–1992.’ South African Medical Journal1994; 84: 195–200.
15. Le Vu S, Pillonel J, Semaille C, Bernillon P, Le Strat Y, Meyer L, Desenclos JC. ‘Principles and HIV incidence estimation from recent infection testing – a review.’ Euro Surveillance2008; 13(36): pii=18969. Available online: http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=18969
16. Podgor MJ, Leske MC. ‘Estimating incidence from age-specific prevalence for irreversible diseases with differential mortality.’ Statistics in Medicine1986; 5: 573–578.
17. Rehle T, Shisana O, Pillay V, Zuma K, Puren A, Parker W. ‘National HIV incidence measures – new insights into the South African epidemic.’ South African MedicalJournal2007; 97(3): 194–199.
18. Saidel T, Sokai D, Race J, Buzingo T, Hassig S. ‘Validation of a method to estimate age specific human immunodeficiency virus (HIV) incidence rates in developing countries using population-based seroprevalence data.’ American Journal ofEpidemiology1996; 144: 214–223.
19. Williams BG, Gouws E, Colvin M, Sitas F, Ramjee G, Abdool Karim SS. ‘Patterns of infection: Using age prevalence data to understand the epidemic of HIV in South Africa.’ South African Journal of Science2000; 96: 305–312.
20. Williams B, Gouws E, Wilkinson D, Abdool Karim S. ‘Estimating HIV incidence rates from age prevalence data in epidemic situation.’ Statistics in Medicine2001; 20: 2003–2016.
21. Williams BG, MacPhail C, Campbell C, Taljaard D, Gouws E, Moema S, et al. ‘The Carletonville-Mothusimpilo Project: Limiting transmission of HIV through community-based interventions.’ South African Journal of Science2000; 96: 351–359.